医学
氨苯砜
白细胞减少症
皮肤病科
贫血
免疫抑制
静脉免疫球蛋白治疗
外科
红斑狼疮
抗体
化疗
免疫学
内科学
作者
Margit Juhász,Megan Rogge,Mary Chen,Annette Czernik,Soo Jung Kim,Lauren Geller
摘要
Abstract This is a case report of a 16‐year‐old girl recently diagnosed with systemic lupus erythematosus ( SLE ) who presented with multiple blisters on the face, hands, arms, legs, trunk, and vaginal and oral mucosa. Skin biopsy was consistent with bullous SLE ( BSLE ). Dapsone is often the first‐line treatment option for BSLE , but the patient's history of anemia and leukopenia and long‐term immunosuppression requirement for her systemic symptoms raised concerns about dapsone and bone marrow toxicity, especially hemolytic anemia and agranulocytosis. She was started on intravenous immunoglobulin (IVIG), 2 g/kg divided over 3 days, with significant improvement in her cutaneous symptoms. IVIG is a treatment option for BSLE patients in whom agents such as dapsone are contraindicated.
科研通智能强力驱动
Strongly Powered by AbleSci AI